Vector

Gene Technology is one of the renowned top access journals in Modern Biotechnology. This journal is a top leading podium for gaining and exchanging knowledge about novel research done in the associated field. Modern Biotechnology are interesting fields which are concerned expression of genes, taking advantage of natural genetic variation, modifying genes and transferring genes to new hosts, Environmental Biotechnology, Cell biology, Genetic Engineering and Molecular Biology, Tissue Engineering, Biosensor, Cancer Biology, Bioinformatics and Computational biology. It involves developing devices and procedures that solve medical and health-related problems by combining their knowledge of biology and medicine with engineering principles and practices. The vector-borne parasitic diseases constitute a group of pathologies caused by eukaryotic pathogens transmitted by arthropods such as Anopheles, sand flies, triatomines and tsetse flies. Malaria, Chagas disease, African trypanosomiasis and leishmaniasis are the most widespread and devastating of the vector-borne parasitic diseases due to their high prevalence and the amount of deaths they cause each year. The rise of molecular techniques and DNA detection has played a prominent role in detecting infections, treatment follow-ups, disease installations and infection outcomes. “Juan David Ramírez, Molecular Diagnosis of Vector-Borne Parasitic Diseases” OMICS Group is one of the top open access publishers with 700+ peer-reviewed journals along with eminent scientists in its Editorial Board and expert reviewers to carry rigorous peer-review process. The peer review process is highly appreciated by researchers globally. Editorial Board Members and Reviewers actively participate in the review process within 21 days and ensure the quality of the manuscripts. In addition to open-access publishing, OMICS also provides E-books, Scholar Central and more than 80 International Scientific Conferences under its umbrella.

• Share this page
• 
• 
• 
• 
• 
• 

Last date updated on April, 2024